| |MARCH 20264The Indian veterinary medicine manufacturing market is currently experiencing rapid growth of 10­14 percent CAGR). This upsurge is being greatly steered by rising livestock, high-value pet care, and government disease control programs. Key hubs in Himachal Pradesh, Gujarat, and Maharashtra produce vaccines, antibiotics, and feed supplements for both domestic and international markets. Going forward, the market is projected to reach over USD 2.2 billion to USD 4.17 billion by 2033.Furthermore, the surge is driven by increased demand for animal-derived protein (dairy), a booming companion animal (pet) market, and government initiatives like the National Animal Disease Control Program (NADCP).Pharmaceuticals dominate with a 65 percent revenue share, while biologics (vaccines) are growing at an 11.2 percent CAGR, wherein, the companion animal segment has shown over 36.6% growth, highlighting a shift towards premium pet care. Today, India acts as a global manufacturing hub, exporting to over various countries. Also to note, the industry is moving toward high-end, specialized products like monoclonal antibodies for pets and advanced vaccines, along with increasing investment in herbal alternatives to combat antimicrobial resistance (AMR). Even the government is boosting the sector through the National Programme for Dairy Development, Rashtriya Gokul Mission, and the Animal Husbandry Infrastructure Development Fund. For instance, the Nandi portal has been introduced to streamline regulatory approvals for new veterinary products.If we speak of some of the most noteworthy manufacturers in this niche, these players have been crucial and essential for ensuring high-quality, safe, and effective treatments that promote animal welfare, support sustainable farming, and safeguard public health. These manufacturers are critical for managing livestock productivity, addressing pet health needs, and combatting antibiotic resistance, often requiring strict adherence to GMP and ISO standards. Furthermore, an expert ensures optimal product quality and is free from contaminants and accurately dosed, ensuring effective treatments rather than relying on potentially unsafe, uncertified alternatives. These manufacturers are known to follow ethical, quality-controlled processes that help reduce the risks associated with indiscriminate antibiotic use in animals.Recognizing the importance played by these manufacturers, India Pharma Outlook brings to you our latest edition - `Top 10 Veterinary Medicine Manufacturers - 2026.' This edition will showcase how the nominated manufacturers have shown their mettle in setting benchmarks in devising veterinary medicines while driving the needed innovation in India's advancing veterinary sector. Shiwani Pradhan Assistant Editoreditor@indiapharmaoutlook.comSetting Quality & Innovation Benchmarks in India's Veterinary SpaceVol 5 · Issue 02 - 03 · MARCH , 2026Publisher Alok ChaturvediManaging EditorSamrat Pradhan Assistant EditorShiwani Pradhan Editorial TeamViswanathan AThiruamuthan T K Lakshmi Prabha GM - Media & Graphic Designing VisualizerPrabhu DuttaDesignerRutika MohantyAdvertising QueriesRahul KumarGM Sales & MarketingRavi kalgisales@indiapharmaoutlook.com Editorial Querieseditor@indiapharmaoutlook.comCirculation Manager Magendran PerumalMagazine Price is Rs. 150 per issuePrinted and Published By Alok Chaturvedi on behalf of Silicon Media Technologies Pvt. Ltd. and Printed at Precision Fototype Services at Sri Sabari Shopping Complex, 24 Residency Road Bangalore-560025 and Published At No. 124, 2nd Floor, Surya Chambers, Old Airport Road, Murugeshpalya, Bangalore-560017.Publisher Alok ChaturvediCopyright © 2026 Silicon Media Technologies Pvt. Ltd., All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher.
< Page 3 | Page 5 >